# OnCo record trutino-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/trutino-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "trutino-biosciences" ;
  schema:name "Trutino Biosciences"@en ;
  schema:description "Trutino Biosciences engineers inactive versions of immune signalling proteins called cytokines that are switched on only inside tumours, aiming to boost the immune attack there without the severe side effects cytokines cause elsewhere. Its first, ODC-IL2, is in an early trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/trutino-biosciences/>, <https://trutinobio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://trutinobio.com/>, <https://trutinobio.com/boehringer-ingelheim-signs-option-to-acquire-trutino-biosciences/>, <https://clinicaltrials.gov/study/NCT06770764> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> .